Impact of previous exposure to SARS-CoV-2 and of S-Trimer (SCB-2019) COVID-19 vaccination on the risk of reinfection: a randomised, double-blinded, placebo-controlled, phase 2 and 3 trial
Igor Smolenov, Htay Htay Han, Ping Li, Carmen Baccarini, Carole Verhoeven, Frank W. Rockhold, Sue Ann Costa Clemens, Donna M. Ambrosino, Peter Richmond, George R. Siber, Joshua G. Liang, Ralf Clemens
Topics & Concepts
ReactogenicityPlaceboMedicineVaccinationAdverse effectRandomized controlled trialCoronavirus disease 2019 (COVID-19)Vaccine efficacyInternal medicineClinical trialInfluenza vaccineImmunologyVirologyAntibodyImmunogenicityPathologyInfectious disease (medical specialty)DiseaseAlternative medicineSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19